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ABSTRACT: Calcium and integrin binding protein 1 (CIB1) is a
specific binding partner for the cytoplasmic domain of the αIIb
subunit of the highly abundant platelet integrin αIIbβ3. This
protein has been suggested to be involved in the regulation of the
activation of αIIbβ3, a process leading to platelet aggregation and
blood coagulation. In this work, the solution structure of the
deuterated Ca2+-CIB1 protein complexed with an αIIb peptide was
first determined through modern RDC-based NMR methods. Next,
we generated a complex structure for CIB1 and the αIIb domain
(Ca2+-CIB1/αIIb) using the program Haddock, which is based on experimental restraints obtained for the protein−peptide
interface from cross-saturation NMR experiments. In this data-driven complex structure, the N-terminal α-helix of the
cytoplasmic domain of αIIb is buried in the hydrophobic pocket of the C-lobe of Ca2+-CIB1. The C-terminal acidic tail of αIIb
remains unstructured and likely interacts with several positively charged residues in the N-lobe of Ca2+-CIB1. A potential
molecular mechanism for the CIB1-mediated activation of the platelet integrin could be proposed on the basis of the model
structure of this protein complex. Another feature of this work is that, in the NMR cross-saturation experiments, we applied the
selective radio frequency irradiation to the smaller binding partner (the αIIb peptide), and successfully detected the binding
interface on the larger binding partner Ca2+-CIB1 through its selectively protonated methyl groups. This ‘reverse’ methodology
has a broad potential to be employed to many other complexes where synthetic peptides and a suitably isotope-labeled medium-
to large-sized protein are used to study protein−protein interactions.
■ INTRODUCTION
Integrins are cell surface receptors that mediate cell adhesion
processes, including cell−cell, cell−extracellular matrix, and
cell−pathogen interactions.
1,2 In general, integrins are hetero-
dimeric glycoproteins that are formed by a single α and a single
β subunit. Both the α and β subunits are single-pass
transmembrane proteins, and such proteins are often involved
in signal transduction processes. Integrins are known to be
involved in bidirectional signal transduction across the plasma
membrane, commonly referred to as “inside-out” and “outside-
in” signaling.
1−3 Both the α and β subunits are made up of a
large extracellular ectomembrane domain, a single trans-
membrane helix, and a small cytoplasmic domain.
1,2 It has
been reported that the dissociation of the cytoplasmic domains
of the α and β subunits is critical for bidirectional trans-
membrane signaling events.
4
The αIIbβ3 integrin heterodimer is exclusively expressed at
very high levels in platelets. Because of its role in the formation
of blood clots and maintaining hemostasis, the structure of this
complex is of particular interest. These two subunits associate
in the membrane and in the cytoplasm with a low affinity.
2 The
interaction between these two parts of the dimeric integrin
protein has been hard to detect in aqueous solution
5 or studies
resulted in different structures, especially for the cytoplasmic
domains of αIIbβ3,
6−8 probably reflecting the dynamic nature
of the cytoplasmic domain of αIIbβ3. In the inside-out signaling
pathway, the cytoskeletal protein talin
9 has been reported to be
able to bind specifically to the cytoplasmic domain of β3 and in
turn activate integrin αIIbβ3.
The calcium- and integrin-binding protein 1 (CIB1) was
originally discovered as a binding partner for the cytoplasmic
domain of αIIb in a yeast two-hybrid screening study.
10 CIB1 is
now known as a ubiquitous regulatory protein that is made up
of four EF-hands
11 with a molecular weight of 22 kDa. CIB1
can carry a myristoyl group at its N-terminus, but the function
of this myristoyl group in vivo is not yet fully understood since
it has been found that CIB1 can interact with αIIb in vitro
without the myristoyl group.
12−14 The myristoyl group of CIB1
appears to act like a membrane anchor, similar to what has been
found for many related calcium-binding proteins.
15 CIB1 has
four helix−loop−helix EF-hand motifs, but only EF-III and EF-
IV have the capacity to bind divalent metal ions.
16 In the resting
state of most cells, magnesium is present in the cytoplasm at
∼1−2 mM allowing the folded form of Mg2+-CIB1 to be
present.
17 When the cell is excited, Ca2+ enters the cytoplasm
and its concentration rises to micromolar levels; Ca2+ displaces
Mg2+ and forms Ca2+-CIB1 in a well-folded conformation.
16
Interestingly, both Ca2+-CIB1 and Mg2+-CIB1 can interact with
a synthetic peptide representing the αIIb cytoplasmic domain
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affinities.
12 Solution NMR studies of CIB1 require deuteration
and methyl group labeling
17,18 because of its relatively large
molecular weight (24 kDa including the purification-tag). It has
been shown that Ca2+-CIB1 and Mg2+-CIB1 have a similar
overall topology with Mg2+-CIB1 having a relatively more
exposed hydrophobic pocket.
17 NMR chemical shift perturba-
tion studies concerning the interaction of αIIb with both Ca2+-
and Mg2+-bound CIB1 suggest that both the Ca2+- and Mg2+-
forms interact with αIIb via a hydrophobic pocket in the C-
terminal domain of CIB1.
17 It has been reported previously that
CIB1 is capable of disrupting the association of αIIb and β3b y
binding to αIIb and in turn activate the integrin αIIbβ3.
14
Furthermore, blocking complex formation between the
Wiskott-Aldrich syndrome protein (WASP) and CIB1 has
been shown to affect the conformational change of αIIbβ3 and
further affects its interaction with fibrinogen.
19 In contrast,
CIB1 has also been suggested to negatively regulate the
activation of integrin αIIbβ3 by competing with talin for
binding to αIIbβ3.
20 Therefore, structural characterization of
the CIB1/αIIb complex is of considerable interest to provide
further insight into the mechanism of the regulation of the
activation of αIIbβ3 by CIB1 or to determine the role of CIB1
in collaborating with talin in the regulation of αIIbβ3 activation
as suggested by Yuan et al.
20 Even though the CIB1/αIIb
interaction has been suggested to be similar to that of the
homologous protein calcineurin B (CnB) with calcineurin A
(CnA) in terms of the relative orientation of the proteins,
13 no
direct experimental results have been reported to date to
support this notion. By determining a structure for the Ca2+-
CIB1/αIIb complex, we hope to obtain insight into the inside-
out signaling of integrin as well as to establish the connections
between the Ca2+-signaling pathway and the integrin-signaling
pathways.
In this work, we report a structure for the Ca2+-CIB1/αIIb
complex. An experimental approach of employing reverse cross-
saturation NMR experiments using the labeled methyl groups
of Ile/Leu/Val (I/L/V) in an otherwise deuterated CIB1
protein has been implemented to accurately identify the
interface for the Ca2+-CIB1/αIIb complex. Moreover, residual
dipolar couplings (RDCs) as determined in multiple alignment
media were used to provide additional information about the
structure of Ca2+-CIB1 in complex with αIIb.
■ MATERIALS AND METHODS
Sample Preparation. The CIB1 protein containing different
stable isotope labels was prepared as previously described.
17,21 The
[U−2H,15N,13C]-labeled sample was used to acquire backbone 1DC′N
and 1DNH residual dipolar couplings (RDCs). The {[U−15N, 2H, 12C];
Ileδ1-[13CH3]; Leu,Val-[13CH3,12CD3]}-labeled sample was used for
the methyl cross-saturation experiments to determine the interface for
the interaction between CIB1 and the human platelet αIIb subunit.
The 26-residue α IIb synthetic peptide (Ac-
L983VLAMWKVGFFKRNRPPLEEDDEEGQ1008-OH) as previously
described
18 was used; this peptide corresponds to amino acids 983−
1008 of the αIIb cytoplasmic domain and part of the transmembrane
domain (hereafter referred to as αIIb-L, Figure 1). Another truncated
15-residue synthetic peptide (Ac-L983VLAMWKVGFFKRNR997-NH2)
(αIIb-S, Figure 1) was also studied, which corresponds to amino acids
983−997 of the αIIb subunit. These synthetic peptides were both
purchased from GenScript Corp. and they were more than 95% pure
as determined by mass spectrometry and HPLC. Protein and peptide
concentrations were determined by using the extinction coefficients:
ε280= 3040 for CIB1, ε280= 5500 for αIIb-L, and ε280= 5500 for αIIb-S.
NMR Experiments. NMR spectra were recorded at 37 °Co na
Bruker AVANCE 500 MHz or a Bruker AVANCE 700 MHz NMR
spectrometer each equipped with a triple resonance inverse cryoprobe
with a single axis z-gradient. Each Ca2+-CIB sample, with or without
αIIb peptides, contained 0.5−0.7 mM CIB1 in 50 mM HEPES, 100
mM KCl, 0.1 mM 2,2-dimethyl-2-silapentane-5-sulfonic acid (DSS),
10 mM DTT, 10% or 99.9% D2O, pH 7.5 ± 0.05; 2 mM CaCl2 was
added for the Ca2+-bound sample and 3 mM MgCl2 for Mg2+-bound
sample. The [U−2H,15N,13C]-labeled Ca2+-CIB1 sample complexed
with αIIb-L was used to acquire the backbone RDCs (1DC′N and
1DNH) in different alignment media. One of the alignment media used
was 14 mg/mL pf1 phage (Asla Lab) for partial alignment of protein
molecules.
22 A second medium used was the polyethylene glycol ether
(PEG) medium containing 5% C12E5/hexanol in 0.96/1 ratio.
23 The
1DC′N RDC were measured using the 3D IPAP-J-HNCO (CA)
experiment,
24 with 1024 × 128 × 40 complex points. The digital
resolution was 2.06 Hz/pt in F2 (13C). A scale factor of 4 was used in
the measurement of the 1DC′N RDCs. The 1DNH RDCs were measured
using the 2D IPAP-HSQC experiment,
25 with 1024 × 512 complex
points, a digital resolution of 1.1 Hz was obtained after linear
prediction and zero filling.
Reverse Methyl Cross-Saturation. Reverse methyl cross-
saturation experiments were performed using 500 μM samples of
{[U−15N, 2H, 12C]; Ileδ1-[13CH3]; Leu,Val-[13CH3,12CD3]}-labeled
CIB1 in 100 mM KCl, 99.9% D2O, 10 mM DTT, 50 mM d18-HEPES
(98% pure) with and without 600 μM αIIb-L at pD 7.5 (not corrected
for isotope effects). Four scans were used, resulting in a total
measurement time of just 40 min. The methyl-based cross-saturation
irradiation using an RF (radio frequency) field was applied as
suggested,
26 which covers from 3.5 to 8.5 ppm with the irradiation
centered at 6.0 ppm, a region including the residual water protons,
amide protons, aromatic protons, most of the α-protons, and some of
the other aliphatic (β and γ) protons of the αIIb-L peptide. Selective
irradiation was done by using the adiabatic WURST-2 band with a
strength up to 0.17 kHz. The saturation time (Tsat) was set at 1.5 s
and the interscan delay was 2 s. On the basis of the spectra with (Tsat
= 1.5 s) and without irradiation (Tsat = 0 s), the signal loss was
calculated using the intensity (I) ratio for each methyl group: Signal
Loss = 1 − [I(Tsat=1.5)/I(Tsat=0)]. Error bars were generated from
duplicates of the cross-saturation experiments.
Structure Calculation. A two-stage simulated annealing ap-
proach
27 based on three sets of 1DNH, 1DC′N RDCs measured in two
alignment media (phage pf1 and organic solvent PEG) was
implemented for the structure determination of Ca2+-CIB1 in complex
with αIIb-L using the program XPLOR-NIH 2.18. This calculation
protocol is designed for studies of homologous proteins or the same
protein under different conditions.
27 Briefly, for stage 1, the
temperature was cooled from 200 to 20 K, and a strong unramped
force constant at 300 kcal mol−1 rad−2 for the dihedral angle (derived
from the chemical shifts of Ca2+-CIB1 in complex with aIIb-L using
the program Talos,
28 after correction for the deuterium isotope
effect
29) was used to ensure proper secondary structure of the
resulting structure. Also in stage 1, the force constant of dipolar
couplings was ramped from 0.05 to 5 kcal mol−1 Hz2−. The obtained
structure still has a certain amount of RDC energy; in stage 2, the
temperature was cooled from 20 to 2 K and the lowest RDC energy
Figure 1. The sequences of the αIIb peptides used in this work. αIIb-L
represents the human integrin αIIb 983−1008 region, in which the
L983, W988, F992, and F993 have been previously identified to be
critical for the interaction between Ca2+-CIB1 and αIIb.
13 αIIb-L
contains part of the transmembrane domain (shaded in gray box) and
the full cytoplasmic domain of integrin αIIb. αIIb-S represents αIIb
residues 983−997. The R995 (red) has been reported to form a salt
bridge with the integrin β3 subunit, which is critical for the association
of the cytoplasmic domain of αIIb and β3.
7,58,59.
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2, the force constant for the dihedral angle (derived from the lowest
energy structure from stage 1) was ramped down from 300 to 50 kcal
mol−1 rad−2 while the force constant for RDC was kept static at 1 kcal
mol−1 Hz−2. Other force constants used in the calculation using Xplor-
NIH were the same as previously described.
17,30 The same approach
has been used successfully to determine the structures of various other
proteins.
30−35 The structure was deposited to the Protein Data Bank
with accession code 2LM5. NMR data were deposited to the BMRB
with the code 18099.
The structure of αIIb-L was generated based on a recent NMR
structure for the transmembrane and cytoplasmic domains of αIIbβ3
(PDB 2KNC).
7 In this study, the αIIb subunit adopts an α-helical
structure from I966 until N996 with an extended C-terminal tail at
R997−E1008. We used the homology modeling program Swiss-Model
web-server
36 to generate the starting structure for αIIb-L, which has a
Q1008 residue
13,18 instead of E1008 at the C-terminal end. The
structure of αIIb-L (L983-Q1008) obtained from homology modeling
is essentially the same as the published αIIb structure in the αIIbβ3
complex.
7 The structure of αIIb-L generated in this manner was used
in the subsequent docking model studies of the Ca2+-CIB1/αIIb-L
complex. In doing so, we assume that the tail of αIIb does not undergo
a large conformational change when it binds to Ca2+-CIB1.
Docking Model of the Ca2+-CIB1/αIIb-L Complex. Using the
refined solution structure of Ca2+-CIB1 in the complex and the
structure of αIIb-L, a docking model for the Ca2+-CIB1/αIIb-L
complex was generated using the Haddock web-server.
37,38 It is known
that the C-terminal extension of Ca2+-CIB1 experiences on/off slow
motions from the hydrophobic pocket in the C-lobe of Ca2+-CIB1 in
solution, thereby blocking nonspecific interactions.
17,18 Hence, in our
calculations, the structure of the complexed Ca2+-CIB1 protein was
truncated in order to avoid blocking the access of αIIb-L to the
hydrophobic pocket of Ca2+-CIB1; the truncated version of Ca2+-CIB1
contains residues 8−178 with the C-terminal tail of the protein
(residues 179−191) removed. In the setup, positive methyl cross-
saturation results were implemented as interfacial restraints for
docking. The significantly affected methyl groups of residues I73,
I114, L131, L135, I153, I168, V176, and I177 were set as the active
residues, while the slightly affected methyl-containing residues I27,
L28, L61, V76, V97, V132, L152, and I156 were set as passive residues
in the Haddock calculations. Residues L983, W988, F992, and F993 in
αIIb-L have been reported to be critical for the interaction between
Ca2+-CIB1 and αIIb-L by a combined approach of site-directed
mutagenesis and in vitro fluorescence studies.
13 Hence, these four
residues were set as the active residues for αIIb-L. Also in the setup,
since αIIb-L residues L983−R995 have been determined to be helical
and the remainder (N996−Q1008) to be an extended structure,
7,39
fragment 995−1008 of αIIb-L was set as fully flexible for the docking
model generation. Because Haddock can automatically detect
semiflexible fragments,
38 CIB1 was not set as fully flexible. RDC
restrains that were used for the structure calculation for the Ca2+-CIB1
in complex with αIIb-L were also implemented in the docking model
generation. In addition, dihedral angle restraints for CIB1 (8−178)
and αIIb-L (983−995) were created based on the lowest RDC energy
structure determined for the Ca2+-CIB1 in protein complex with αIIb-
L as well as the available αIIb structure (PDB 2KNC) in complex with
β3.
7 Other parameters were standard default values except that 3000
structures were calculated for the stage of rigid body docking, 400
structures for the subsequent structural analysis stage, and 20
structures were set as the minimal number for clustering.
37,38 The
lowest interaction energy docking structure cluster was taken as the
complex model for Ca2+-CIB1/αIIb-L.
Further Characterization of Calculated Structures. The lowest
RDC energy structures of Ca2+-CIB1 (residues 8−191) in complex
with αIIb-L were selected for further analysis. Procheck 3.5.4
40 was
used to examine the structures determined for stereochemical quality.
An in-house script was used to measure the interhelical angles for the
helix pairs in each EF-hand.
■ RESULTS
The Solution Structure of Ca2+-CIB1 in Complex with
αIIb-L Reveals an Enlarged Hydrophobic Pocket
Induced by αIIb-L Binding. The solution structure (Figure
2) of the Ca2+-CIB1 protein in complex with αIIb-L was refined
based on three sets of backbone RDCs obtained in two
alignment media (NH and C′N RDCs in pf1, and NH RDCs in
PEG) using the solution structure of Ca2+-CIB1 (PDB 2L4H)
as the starting model and a two-stage low-temperature
simulated annealing protocol.
27 The use of multiple sets of
alignment media has been previously suggested because it can
avoid the intrinsic degeneracy problem of using RDCs as well
as avoid any preference for a minor conformation that could
result from the use of a single alignment medium.
41,42 Some
residues on the flexible loop of CIB1 (residues 137−145) and
the C-terminal end (180−191) have reduced RDC values due
to local mobility,
43,44 and these residues were excluded from
the structure calculation.
45 A good structural precision has been
obtained for the structure calculation; the backbone rmsd of the
Figure 2. The structure of Ca2+-CIB1 in complex with αIIb-L. (A)
Superposition of the best 10 structures of the Ca2+-CIB1 protein in
complex with αIIb-L; (B) superposition of the solution structures of
Ca2+-CIB1 alone (PDB 2L4H, cyan) and in complex with αIIb-L
(pink) (backbone rmsd = 3.7 Å). (C) The superimposed structures of
the C-lobe of Ca2+-CIB1 alone (cyan) and in complex with αIIb-L
(pink) demonstrate the increased opening of helix pairs H6/H7 and
H8/H9. The two structures were superimposed based on H7 and H8;
thus, the opening is highlighted by the altered orientations of H6 and
H9.
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of the structure determination of the Ca2+-CIB1 protein when
complexed with αIIb-L have been summarized in Supporting
Information Table S1. The solution structure of the Ca2+-CIB1
protein in the complex also shows a similar overall topology
compared with the solution structure of Ca2+-CIB1 alone, with
a backbone rmsd of 3.7 Å (Figure 2B). Compared with the
Ca2+-CIB1 structure, the N-terminal α-helix (Helix 0, H0) in
the new structure has shifted to some extent. The N-terminal α-
helix is assumed to carry a myristoyl group in vivo which should
associate with the cell membrane. Therefore, binding of αIIb-L
could affect the orientation of CIB1 relative to the cell
membrane. Moreover, the interhelical angles measured using an
in-house script suggest that the opening of the helix pairs in
each EF hand changes upon binding aIIb. (Table S2). The two
EF-hands in the C-lobe have a bigger interhelical opening than
free Ca2+-CIB1 by approximately 20° (Figure 2C). The
resultant enlarged hydrophobic pocket in the C-lobe could
readily adopt aIIb. The Q factors
46 (Table S3 and Figure S1)
before and after structural refinement denote a significant
improvement in the results of fitting RDCs to the obtained
structure of Ca2+-CIB1 complexed with αIIb-L compared with
the starting model, that is, the free Ca2+-CIB1 structure (PDB
2L4H).
Reverse Cross-Saturation Detects the Interface of the
Ca2+-CIB1/αIIb-L Complex. Cross-saturation NMR experi-
ments employing backbone amide proton NH resonances were
originally developed to detect the interface for protein−protein
interactions.
47 Compared with the commonly used NMR
Chemical Shift Perturbation (CSP) approach, which is widely
used for determining the interface of protein/peptide
complexes, the cross-saturation method avoids possible artifacts
arising from induced conformational changes, where residues
that experienced a large chemical shift change can in fact be far
away from the actual interface.
48 A more recent version of the
cross-saturation experiment uses isotope labeled methyl groups
rather than backbone amides.
26 It has several advantages over
the traditional cross-saturation backbone 15N−H method,
47
such as high sensitivity, higher efficiency of magnetization
transfer, and suitability for studying hydrophobic interactions
that are often involved in protein/protein complex formation.
26
Traditionally, the cross-saturation approach has been used to
detect the binding interface of the smaller partner by irradiating
the larger partner because the magnetization will be more
efficiently transferred by spin diffusion
49 in a larger protein. In
our work, we applied the selective irradiation in a reverse
manner (referred to as reverse cross-saturation), in a way that is
somewhat similar to previous studies.
50,51 We saturated the
smaller binding partner (αIIb-L, 3 kDa) to detect the interface
on the larger binding partner (Ca2+-CIB1, 24 kDa including the
purification His-tag) (Figure 3). In our methyl-probe cross-
saturation experiments, selective irradiation was employed to
cover the spectral region from 3.5 to 8.5 ppm (Figure S2). To
avoid artifacts, 99.9% D2O was used as the solvent.
26 In the
spectral area from 3.5 to 8.5 ppm (Figure S2), methyl labeled
but otherwise perdeuterated Ca2+-CIB1 has no signals except
for some peaks due to the d18-HEPES buffer (98% pure) used
to dissolve the Ca2+-CIB1/αIIb-L complex, while αIIb-L
contains aromatic protons, aliphatic proteins (Hα,H β,H γ,
etc.) and no amide protons (NH) because of the presence of
the D2O solvent (Figure S2). Therefore, the irradiation
selectively targets αIIb-L but not the deuterated CIB1. This
saturation should then be transferred to the protonated methyl
groups involved in the Ca2+-CIB1/αIIb-L interface by spin-
diffusion (Figure 3). The interface of CIB1 in its complex with
αIIb-L can therefore be accurately mapped using cross-
saturation experiments.
48 The results for these experiments
are shown in Figure 4. In this case, control experiments were
carried out on an NMR sample containing only Ca2+-CIB1, and
the results show that all the methyl groups were evenly affected
to a minimum level (half of all methyls are below 0.1 and the
other half are between 0.1 and 0.2 in terms of signal loss)
(Figure 4C). Since the irradiation pulse was suggested to be
adiabatic,
26 the signal loss in the control experiments is
probably due to the presence of residual protons of the d18-
HEPES buffer (50 mM, 98% pure) (Figure S2; for further
discussion see Shimada
48,51).
To identify the interface between Ca2+-CIB1 and αIIb-L, an
identical setup as the one used for the control experiments was
used for a sample of Ca2+-CIB1 complexed with 1/1.2 ratio of
αIIb-L. The results obtained are illustrated for the super-
imposed HSQC spectra of the Ile region (Figure 4A1). With
irradiation, the I73, I114, and I177 residues show significant
signal loss compared to the reference spectrum (Tsat = 0 s)
(Figure 4A2 and B), whereas other methyl protonated
isoleucines (e.g., I58, I106, I162, and I189) are relatively less
affected by the cross-saturation. The significantly affected
methyl-containing Ile, Leu, and Val residues with a signal loss
ratio above 0.3 include I73, I114, L131, L135, I153, I168, V176,
and I177 (Figure 4B), and these were classified as the active
residues in the Ca2+-CIB1/αIIb-L interface that make direct
contact with the binding partner αIIb-L. Other slightly affected
methyl-containing residues with signal loss ratio between 0.2
and 0.3, which include I27, L28, L61, V76, V97, V132, L152,
and I156 (Figure 4B), have been classified as passive residues
that are close to the interface, but lack direct contact with αIIb-
L. The remaining peaks are the nonaffected or marginally
affected methyl groups with a signal loss ratio less than 0.2
(Figure 4B), and these are considered not involved in the
hydrophobic interactions between the protein and the peptide.
The cross-saturation effects were mapped on the newly
determined structure of Ca2+-CIB1 in complex with αIIb-L
(Figure 5B). Compared with methyl CSP (chemical shift
perturbation) effects (Figure 5A), cross-saturation experiments
provide a similar interface for the interactions between Ca2+-
CIB1 and αIIb-L, suggesting that the C-domain of Ca2+-CIB1 is
the primary binding site for the cytoplasmic domain of αIIb.
Figure 3. Schematic diagram illustrating the mechanism of the reverse
methyl cross-saturation for the Ca2+-CIB1/αIIb-L complex. Selective
RF (Radio Frequency) irradiation was applied to the Hα,H β, and
aromatic proton spectral region of αIIb-L, and the intensity change of
the protonated methyl groups on deuterated Ca2+-CIB1 was
monitored.
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observed; the distribution of active interfacial residues from the
cross-saturation experiments (Figure 5B) seems to suggest one
possible orientation for the αIIb-L peptide, whereas two
possible orientations were suggested by CSP (Figure 5A).
Clearly, a majority of the significantly affected methyl groups
are found in the C-lobe of Ca2+-CIB1, except for residue I73,
which is in the N-lobe.
The previously discussed C-terminal displacement mecha-
nism for CIB1
18 allows us to interpret our methyl cross-
saturation results. The C-terminal extension of CIB1 undergoes
a conformational transition between free and bound states as
suggested by our earlier backbone relaxation and relaxation
dispersion measurements.
17,18 The three assigned methyl
groups on the C-terminal extension of Ca2+-CIB1, that is,
I189δ1, and V190γ1 and γ2, are only marginally affected by the
saturation from αIIb-L, which suggests that these three residues
are not in direct contact with αIIb-L in the complex. Thus, the
cross-saturation results are consistent with the backbone
relaxation and relaxation dispersion results regarding the
flexibility of the C-terminal extension; the extension remains
flexible when the protein binds to αIIb-L.
17,18
αIIb-L Has an N-Terminal α-Helix and an Extended C-
Terminal Tail. Initial attempts of using isotope-filtered
52 or
transferred NOESY experiments
53 to determine the structure of
αIIb-L in complex with Ca2+-CIB1 failed to provide sufficient
intermolecular NOEs between αIIb-L and Ca2+-CIB1. Even
though NMR titration experiments (results not shown) suggest
that the interaction between these two is in slow exchange
regime, previous studies
12 suggested that αIIb interacts
relatively weakly with Ca2+-CIB1 with a dissociation constant
(Kd) of 1.4 μMa t3 7°C. This exchange behavior seems to have
hindered the determination of the solution structure of αIIb-L
in complex with Ca2+-CIB1. Isotope-labeled αIIb-L was then
prepared through bacterial expression as a fusion protein but
the solubility in aqueous solution became a problem, even
Figure 4. Reverse methyl cross-saturation experiment of the Ca2+-CIB1/αIIb-L complex. (A) HSQC spectra of Ca2+-CIB1/αIIb-L showing the
effects of saturation on the Ile residues. The spectrum on the left is the 1H, 13C-HSQC with no saturation, and the spectrum on the right includes
selective saturation. (B) Signal loss ratio of the intensities of the methyl groups in Ca2+-CIB1 complexed with αIIb-L, with and without the selective
irradiation. The signal losses over 30% and 20% were highlighted with gridlines and these results were further utilized in the generation of docking
complex structural model for Ca2+-CIB1 and αIIb-L using the program Haddock. (C) Control experiment of methyl cross-saturation with the free
Ca2+-CIB1: only a minimum saturation effect was observed on nearly all methyl groups.
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quite soluble. Fortunately, a structure for the αIIb subunit
(including the transmembrane and cytoplasmic domains)
(PDB 2KNC), in complex with β3, has recently been reported.
7
This structure of αIIb (PDB 2KNC) covers the fragment of
αIIb-L used in our work (residues 983−1008). It is strikingly
similar to a structure previously determined in a 45%
trifluoroethanol aqueous solution for the synthetic αIIb-L
peptide,
39 containing a typical α-helical structure (L983−
N996) followed by an extended tail (R997−Q1008).
In addition, it should be noted that the C-terminal extension
of CIB1 in the crystal structure of Ca2+-CIB1 (1XO5) is folded
back into the protein and adopts an α-helical conformation
(Figure S3). This implies that the hydrophobic pocket in the C-
domain of Ca2+-CIB1 can readily accommodate a binding
partner in an α-helical conformation. Therefore, we suggest that
it is reasonable to assume that the fragment L983−R997 adopts
an α-helical conformation when interacting with Ca2+-CIB1.
The Structure of the Ca2+-CIB1/αIIb-L Complex
Reveals a Relative Orientation Similar to CnB/CnA. The
solution structure of the Ca2+-CIB1/αIIb-L complex has been
determined by data-driven docking. The 20 lowest energy
structures of the Ca2+-CIB1/αIIb-L complex are displayed in
Figure 6 in both ribbon and surface charge forms. In Figure 6A,
the N-terminal helical part of αIIb-L interacts with the C-
domain of Ca2+-CIB1, while the negatively charged C-terminal
tail of αIIb-L remains unstructured (Figure 6A), possibly
interacting with some positively charged residues, for example,
R33 and K65 as was suggested by backbone CSP measure-
ments.
18 In our docking experiment setup, we solely relied on
the methyl cross-saturation results for Ca2+-CIB1 and on
previously reported critical residues in αIIb-L;
13 thus, these
restraints do not reflect any potential electrostatic interactions.
Therefore, the relative orientation of these two partners was
mostly driven by the enthalpy of the hydrophobic interactions
between the αIIb-L helix and the C-domain of Ca2+-CIB1. A
related situation is found for the structure of the homologous
protein calcineurin B (CnB) complexed with calcineurin A
(CnA) (PDB 1TCO) (Figure 6C), in which the C-terminal
domain of CnB interacts with the N-terminal of the CnB
binding domain of CnA, with the CnB binding domain of CnA
adopting an α-helical conformation. Regarding the structure of
the acidic tail (P998PLEEDDEEGQ1008)o fαIIb, we attempted
to dock this portion better by adding R33 and K65 (residues
identified by backbone CSP) of CIB1 as heavily affected
residues but the tail still remained dynamic probably because no
restraints were available for this portion of the αIIb tail.
The Model Is Supported by NMR Studies of the
Interactions of Ca2+-CIB1 with αIIb-L and αIIb-S. A shorter
Figure 5. Mapping the reverse cross-saturation effect on the structure. (A) Mapping the methyl Chemical Shift Perturbation (CSP) on the structure
of Ca2+-CIB1 in complex with αIIb; the methyl CSP values were previously reported;
17 (B) mapping the signal loss values from reverse cross-
saturation experiments on the structure of Ca2+-CIB1 in complex with αIIb. In both panels, the dotted lines (red) resemble possible orientations of
αIIb-L in its complex structure with Ca2+-CIB1.
Figure 6. Structural model for the Ca2+-CIB1/αIIb-L complex. (A)
The superposition of the 20 best structures of the Ca2+-CIB1/αIIb-L
complex generated using Haddock. (B) The Ca2+-CIB1 (8−178)
protein is represented with a surface structure, while aIIb-L is
represented as a ribbon structure. This figure was generated with the
program MolMol.
63 The surface polarity is scaled with colors, using
blue for the positively charged surface and red for the negatively
charged surface, while a white color indicates nonpolar patches. (C)
The surface charge model for the complex of CnB/CnA (PDB
1TCO), in which CnB is presented with a surface structure and CnA
(residues 340−373) is presented as a ribbon structure.
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L983VLAMWKVGFFKRNR997-NH2) was synthesized to exam-
ine the role of the acidic tail of αIIb in its interaction with Ca2+-
CIB1. Specifically, the difference between the αIIb-L and αIIb-S
peptides resides in the C-terminal fragment
P998PLEEDDEEGQ1008, which bears multiple negative charges,
making this region of αIIb extremely acidic. In Figure S4A, the
superimposed HSQC spectra of Ca2+-CIB1/αIIb-L and Ca2+-
CIB1/αIIb-S show small differences with a few methyl groups
experiencing minor chemical shift changes. This suggests that
the C-terminal fragment P998PLEEDDEEGQ1008 was not
involved in specific interactions with Ca2+-CIB1, which could
affect the interactions between Ca2+-CIB1 and αIIb-L. The
residues (L8, V45, V76, L92, L94, V97, I 106, and L170) with
minor chemical shift changes are mainly located in the N-lobe
of CIB1. On the other hand, these shifted methyl groups do not
center at a specific location in the structure, implying a dynamic
interaction between the N-lobe of CIB1 and the acidic tail
(P998PLEEDDEEGQ1008). Perhaps this region of αIIb can
associate with other protein binding partners. A recent study
54
shows that this part of the αIIb cytoplasmic domain can in fact
play a role in platelet activation, but it only does so when it is
anchored to the inner surface of the membrane.
The Potential Roles of Mg2+and Ca2+ in the
Regulation of CIB1/αIIb Interaction. Since Mg2+ ions are
present in the cytoplasm with an almost invariant concentration
of around 1−2 mM and the structure of Mg2+-CIB1 is overall
similar to that of Ca2+-CIB1,
16,17 we were interested in the
structural differences between the complexes of CIB1/αIIb-L
when bound to Ca2+ and Mg2+, in order to further understand
the role of Ca2+ in the regulation of the CIB1/αIIb interaction.
Therefore, 1H,13C-HSQC spectra for the methyl groups of
CIB1 complexed with αIIb-L were recorded in the presence of
either Ca2+ or Mg2+ (Figure S4B). Similar to the backbone
NMR studies,
55 methyl side chain 1H,13C-HSQC spectra for
Ca2+- and Mg2+-bound CIB1/αIIb-L show nearly the same
pattern with minor deviations except for two residues in the
calcium/magnesium binding loop, I168 and L123 (Figure S4B).
These results suggest that Ca2+-CIB and Mg2+-CIB1 interact
with αIIb in nearly the same manner.
■ DISCUSSION
In this study, we have obtained a solution structure for the
isotope-labeled Ca2+-CIB1 protein, complexed with the
synthetic αIIb-L peptide that encompasses the cytoplasmic
domain and part of the transmembrane domain of the αIIb
subunit of platelet integrin. The structure for the complexed
protein could be determined based on RDC restraints. With the
use of the available structure of αIIb (PDB 2KNC), a structural
model for the Ca2+-CIB1/αIIb-L complex was obtained using
data-driven docking based on reverse cross-saturation NMR
experiments. The two binding partners in this complex
structure adopt a relative orientation with the α-helical N-
terminal portion of αIIb-L buried into the C-lobe hydrophobic
pocket of Ca2+-CIB1 and the negatively charged and extended
C-terminal tail of αIIb-L pointing toward the N-lobe of Ca2+-
CIB1 but being relatively dynamic. The superposition of the
ordered structural fragment (residues 983−995) and the
corresponding fragment of 2KNC provides the orientation of
the Ca2+-CIB1/αIIb-L complex relative to the cell membrane
(Figure 7A). As expected, the N-terminal extension of Ca2+-
CIB1(helix 0, H0) points toward the cell membrane, which is
consistent with its role in linking to a membrane-bound
myristoyl group (Figure 7A). However, when modeled together
with a membrane, a steric clash was observed between the
transmembrane helix of αIIb and the eighth helix of Ca2+-CIB1
(H8) (Figure 7A). Moreover, CIB1 would become associated
directly with the membrane to a large extent if the αIIb subunit
interacts with Ca2+-CIB1 with both of its transmembrane and
cytoplasmic domains. Since CIB1 is mainly found as a
myristoylated protein in the cytoplasm
3,56 and the binding
interface on αIIb primarily includes the fragment of 983−995,
3
it seems unlikely that Ca2+-CIB1 will penetrate into the cell
membrane or be engaged with a significantly large part of the
αIIb transmembrane domain. Therefore, a conformational
change is likely to happen in αIIb upon binding to Ca2+-CIB1.
We propose that the transmembrane helix of αIIb will bend
around W988 (the membrane-border residue for αIIb-L) when
binding to Ca2+-CIB1 (Figure 7B,C). In this manner, the steric
clash and the potential energy barrier caused by an intrusion of
CIB1 into the membrane would be avoided.
Recent structural studies of the transmembrane domains
57,58
as well as the protein fragments including both the trans-
membrane and cytoplasmic domains of αIIbβ3
7,8 have shed
some light on the molecular mechanism of the regulation of the
activation of αIIbβ3. For the structure of the αIIbβ3
transmembrane domains, various approaches gave rise to
almost converged structures (see detailed analysis in Yang et
Figure 7. Possible conformational changes of αIIb upon binding of Ca2+-CIB1. (A) Superposition of the ordered structural fragment (983−995) of
the averaged structure of αIIb-L complexed with Ca2+-CIB1 with the corresponding fragment of 2KNC. A steric clash was observed between 2KNC
and the 8th helix of Ca2+-CIB1 (H8, brown color); The N-terminal extension of Ca2+-CIB1 (H0, pink color) points toward the cell membrane,
which is consistent with its role of linking the myristoyl group and the Ca2+-CIB1 to a membrane. (B) The side view of (A); (C) a possible bending
mechanism was proposed for the conformational change of αIIb upon binding of Ca2+-CIB1, as indicated by the red dashed line with arrows. The
letter N in italics indicates the N-terminal of Ca2+-CIB1.
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7 and Metcalf et al.
57). However, the structure of the
cytoplasmic domains of αIIbβ3 was reported to be diverse.
7,8
The importance of the previously suggested salt bridge between
αIIb R995 and β3 D723
7,59 that was considered for a long time
to be critical for the association of αIIbβ3 has recently been
brought into question,
8,60 consistent with the dynamic nature of
the cytoplasmic domains of αIIbβ3. The G991FFKR995 motif on
αIIb is critical for the interactions between αIIb and β3a s
revealed in the αIIbβ3 complex structure determined using
Cys-scanning-mutagenesis/disulfide-cross-linking/rosetta-mod-
eling
61 and another αIIbβ3 complex NMR structure that has
been determined using lipid bicelles as the solvent (PDB
2K9J).
58 On the basis of a comparison with these two
structures, Ca2+-CIB1 seems to dissociate the αIIbβ3
heterodimer, which would potentially activate the αIIbβ3
complex
14 because the F992 and F993 side chains become
buried in the hydrophobic pocket in the Ca2+-CIB1/αIIb-L
complex structure (Figure S5). It has also been reported that an
F992A mutation in αIIb may partially impair the interaction
with β3 although both F992 and F993 in αIIb point away from
the β3 subunit in 2KNC.
7 Moreover, a potential conformational
change of αIIb upon binding to Ca2+-CIB1 (Figure 7) will also
disturb the stability of the structure of the αIIbβ3 complex and
cause the dissociation of these two subunits. On the basis of the
classic studies indicating that the activation of integrin can be
caused by the dissociation of the heterodimer,
4 Ca2+-CIB1 is
highly likely able to disrupt the association of αIIb and β3.
■ CONCLUSION
Taken all data together, a mechanism for activation of αIIbβ3
upon interacting with Ca2+-CIB1 can be proposed, that is
similar to the action of the cytoskeletal protein talin,
9 where
Ca2+-CIB1 dissociates the αIIbβ3 heterodimer and conse-
quently activates integrin αIIbβ3 (Figure 8). Alternatively CIB1
can maintain the activated state of αIIbβ3 by covering the
binding site in αIIb and preventing its association with β3.
Since nearly identical HSQC NMR patterns were observed for
Mg2+-CIB1 and for Ca2+-CIB1 upon interaction with αIIb-L
(Figure S4B), our data suggest that the same complex can form
under various physiological conditions and is not calcium-
dependent per se. This notion is supported by previous in vivo
studies, in which αIIb was shown to interact with CIB1 in both
resting and stimulated platelets with no requirement for a rise
in the intracellular calcium concentration.
19 In addition, it is
possible that protein phosphatase 1 could compete with CIB1
for αIIb, as these two proteins share the same binding motif
(K989VGF992) on the αIIb cytoplasmic domain.
62
In this work, we have used a reverse cross-saturation NMR
approach to detect the interface on Ca2+-CIB1 that recognizes
the bound αIIb-L peptide. In these experiments, we selectively
irradiated the smaller partner in the protein−protein complex,
and the results from our work (Figure 4 and Figure 5)
demonstrate that it is possible to identify the hydrophobic
residues that are involved in the interactions between CIB1 and
αIIb. This represents a powerful way of using the NMR cross-
saturation experiment, where normally the larger partner has
been irradiated to achieve more effective spin-difussion.
26,47
Many protein complexes currently under investigation can be
represented by studying a large protein and a synthetic peptide
to represent the intact protein partner or a protein domain.
Provided that the proteins of interest can be bacterially
expressed, deuterated, and selectively protonated on methyl
groups, the reverse cross-saturation experiment with methyl
detection should become a useful NMR approach for better
understanding protein−protein interactions in general.
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1XO5); Figure S4 shows the superposition of 2-D NMR
HSQC spectra demonstrating the roles of the acidic tail of αIIb-
L, as well as Ca2+ and Mg2+ in the regulation of the CIB1/αIIb
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